OB/GYN

CEO Peter Meldrum said at a conference this week that Myriad's sales force "provides doctors [with] the tools to do counseling" in-house, and as a result, physicians can bill insurers directly for the service.

More OB/GYN sales reps, expanded direct-to-consumer marketing campaigns, and more company-hired physicians reaching out to other doctors are a few “initiatives [that] will be beneficial to the company in combating this weak economy,” Myriad CEO Peter Meldrum said during an earnings call this week.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.